ARCHIVES

Upton Still Mum On Leaving; DeVita Ever More Likely as Replacement

This article is from The Cancer Letter archive.

Vol. 05 No. 48 | November 30, 1979

Download PDF Visit The Full Archive

Related Articles

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

August 26, 2005

New Opportunities Still Abound In Immunology Program, Terry and other NCI Executives Say

February 27, 1976

Rauscher For Cancer Program

May 20, 1977

New Research Grant Awards

December 13, 1974

UICC Announces Four Grant award Programs

July 14, 1978

Fisher Seeks Damages Under Privacy Act; NIH Consents To Remove Database Flags

March 10, 1995